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Abstract
Adequate vitamin D intake and its status are important not only for bone health and Ca-P metabolism, but for optimal function of many
organs and tissues throughout the body. Due to documented changes in dietary habits and physical activity levels, both observed in
growing children and adults, the prevalence of vitamin D insufficiency is continuously increasing. National consultants and experts in the
field have established some Polish recommendations for prophylactic vitamin D supplementation in infants, toddlers, children, and ado-
lescents as well as in adults, including pregnant and lactating women basing on a review of current literature.
(Pol J Endocrinol 2010; 61 (2): 228–232)
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Streszczenie
Odpowiedni stan zaopatrzenia ustroju w witaminę D jest istotny nie tylko dla prawidłowego funkcjonowania układu szkieletowego
i utrzymania homeostazy wapniowo-fosforanowej, ale również funkcji wielu innych narządów i tkanek w naszym organizmie. W związku
ze zmianą stylu życia obejmującą zmianę nawyków żywieniowych, powszechne stosowanie filtrów UV oraz mniejszą aktywność na
świeżym powietrzu obserwuje się wzrost odsetka niedoborów witaminy D w populacji zarówno wieku rozwojowego, jak i u osób doro-
słych. Opierając się na wynikach najnowszych badań naukowych, zespół ekspertów przedstawia polskie zalecenia dotyczące profilak-
tycznej podaży witaminy D u niemowląt, dzieci, młodzieży i dorosłych, w tym kobiet ciężarnych i karmiących piersią.
(Endokrynol Pol 2010; 61 (2): 222–232)
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Introduction
There is a great deal of concern about the continuously
increasing prevalence of vitamin D insufficiency in dif-
ferent age groups in the Polish population [1–3]. Vita-
min D deficiency may cause not only rickets, osteoma-
lacia, and osteoporosis but also may increase risk of
many others diseases, e.g. diabetes, cancers (breast, co-
lon, prostate), autoimmunological disease (multiple scle-
rosis, rheumatoid arthritis, lupus), cardiovascular dis-
eases, and metabolic syndrome [3]. Taking into consid-
eration pleiotropic vitamin D action and safety aspects,
maintaining appropriate vitamin D status is a crucial
issue.
Serum 25- hydroxyvitamin D level (25-OHD — the
main circulating vitamin D metabolite — is used to clas-
sify vitamin D status. Serum 25-OHD levels of 20–
–60 ng/mL (50–150mmol/L) in children and 30–80 ng/mL
(75–200 nmol/L) in adults are considered optimal [3–8].
Adequate vitamin D and calcium supply (Table I) as
well outdoor physical activity are essential for appro-
priate bone growth and mineralization, and civilization
diseases risk reduction. A diversified diet rich in food
containing large amounts of calcium and vitamin D in-
cluding milk, dairy products, and fish is extremely im-
portant (Tables II, III). If dietary vitamin D and calcium
consumption are insufficient, the use of pharmacologi-
cal preparations are essential.
Exposure to sunlight—inducing vitamin D produc-
tion in the skin—is the main endogen source of vita-
min D in the body. Importantly, the sunscreens which
are widely used nowadays may reduce skin synthesis
by 90% [3, 9]. In Poland, skin synthesis is effective from
April to September if there is exposure of 18% of the
body surface to the sun (uncovered forearms and part-
ly uncovered legs) without using sunscreen for 15 min-
utes a day between 10 a.m. and 3 p.m. [6, 10]. There is
no skin synthesis from October to March [3, 6, 10]. We
should balance the advantages and disadvantages of
sun exposure providing appropriate vitamin D status,
at least during summer, but also being a potential risk
factor of skin cancer. Direct exposure to the sun is not
recommended for infants below 6 months of age [3,4].
Table II. Foods with calcium content (240 mg) equal to one
medium glass of milk [8]
Tabela II. Produkty żywnościowe odpowiadające pod
względem zawartości wapnia (240 mg) jednej średniej
szklance mleka [8]
One cup of yoghurt
Jeden mały kubeczek jogurtu (150 g)
One cup of kefir
Jedna szklanka kefiru
One cup of buttermilk
Jedna szklanka maślanki
35dkg cottage cheese
35 dkg sera białego
4–5 pancakes with cottage cheese
4–5 naleśników z serem
Two small pieces of processed cheese
Dwa małe „trójkąciki” serka topionego
Two slices of hard cheese
Dwa plasterki sera żółtego
Table I. Calcium supply (sufficient intake) in age groups [7]
Tabela I. Podaż wapnia (wystarczające spożycie) w grupach
wiekowych [7]
Age Calcium (mg/day)
Grupa wiekowa Wapń (mg/d.)










Adolescents 10–18 years 1300
Nastolatki 10–18 lat
Adults 19–50 years 1000
Dorośli 19–50 lat
> 50 lat 1300
> 50 years
Women < 19 years 1300
(pregnancy, > 19 years 1000
lactation)
Kobiety (ciąża < 19 lat
i laktacja) > 19 lat
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• all newborns should be supplemented with 400 IU/d
of vitamin D beginning from the first few days
of life
2. Preterm newborns
• vitamin D supplementation should be introduced
from the first few days of life (if enteral feeding is
possible) and followed up to the corrected age of
40 weeks post conception;
• total vitamin D intake from all sources should be
400–800 IU/day [5, 11, 12] (in the case of formula
feeding or breast milk with fortifier feeding, the
regimen take into account vitamin D intake from
the diet);
• subsequent (beyond 40 weeks post conception)
vitamin D dose should be 400 IU/d, as in term
infants.
3. Term infants
• breastfed infants should be supplemented with
400 IU/d of vitamin D*
*Breastfeeding mother supplementation with vitamin
D up to 2000 IU/d does not require any change in the
infant’s vitamin D dosage [13, 14]
• formula fed infants should be supplemented with
400 IU/d of vitamin D (total intake from diet and
supplements).
• if formula consumption ensures 400 IU/d (about
1000 mL of beginning formula and about 700–800 mL
of follow-up formula), additional vitamin D supple-
mentation is not necessary.
• in the case of mixed feeding (mother’s milk and for-
mula milk), the dosage of vitamin D should be de-
fined by a physician, taking into account vitamin D
intake from the formula. Vitamin D intake from
human milk may be omitted because of its very low
vitamin D concentration (about 50 IU/L).
4. Children and adolescents (2–18 years)
• total vitamin D intake from all sources (diet and/or
supplements) should be 400 IU/d between October
and March, and throughout the whole year in the
case of inadequate vitamin D skin synthesis during
the summer time;
• in overweight/obese children, supplementation with
a higher dosage of vitamin D 800–1000 IU/d should
be considered.
5. Adults
• total vitamin D intake from all sources (diet and/or
supplements) should be 800–1000 IU/day between
October and March, and throughout the whole year
in the case of inadequate vitamin D skin synthesis
during the summer time.
• in patients over 65 years of age, due to reduced skin
synthesis and the evidenced anti-fracture and anti-
fall effect, supplementation with 800–1000 IU/d of
vitamin D throughout the year is recommended.
6. Pregnant and lactating women
• it is important to ensure proper vitamin D resources
before planning pregnancy;
• vitamin D intake in a dose of 400 IU/d (equal to that
derived from multivitamin supplements for preg-
Table III. Vitamin D content of foods [8]
Tabela III. Zawartość witaminy D w polskich produktach
żywnościowych [8]
Food Vitamin D content
Produkt Zawartość witaminy D
Fresh eel 1200 IU/100 g
Węgorz świeży
Pickled herring 480 IU/100 g
Śledź marynowany
Herring in oil 808 IU/100 g
Śledź w oleju
Fresh cod 40 IU/100 g
Dorsz świeży
Boiled/backed salmon 540 IU/100 g
Gotowany/ pieczony łosoś
Boiled/baked mackerel 152 IU/100 g
Gotowana/pieczona makrela
Canned fishes (tuna, sardines) 200 IU/100 g
Ryby z puszki (tuńczyk, sardynki)
Egg yolk 54 IU/żółtko
Żółtko jajka
Cheese 7,6–28 IU/100 g
Ser żółty
Breast milk 1,5–8 IU/100 mL
Pokarm kobiecy
Cows’ milk 0,4–1,2 IU/100 mL
Mleko krowie
Milk-corny gruels 160–480 IU/100 g
Kaszki mleczno-zbożowe (64–80/100 mL)
Infant formula (Beginning formula) 40–50 IU/100 mL
Mleko początkowe
Infant formula (Follow-up formula) 40–80 IU/100 mL
Mleko następne
Formula for children >1 year of age 70–80 IU/100 mL
Mleko modyfikowane > 1rż.
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nant/lactating women) is not sufficient to build ap-
propriate vitamin D status in pregnant/lactating
women and their offspring [3–5, 14];
• supplementation with 800–1000 IU/d of vitamin D
beginning in the second trimester of pregnancy is
recommended in cases of inadequate intake from
diet and/or skin synthesis;
• determination of vitamin D status should be con-
sidered by measurements of serum 25(OH)D level
to define the optimal dosage and assess the efficacy
of supplementation. The goal of the supplemen-
tation is to obtain and maintain 25-OHD level
> 30 ng/mL. Monitoring of serum calcium and its
urinary excretion should be also considered;
• some authors emphasize the need for vitamin D sup-
plementation with more than 1000 IU/d [3–5, 13, 14].
7. Treatment of severe vitamin D deficiency
[6, 8, 9]
• Severe vitamin D deficiency (25-OHD < 10 ng/ml)
requires treatment dosage for 3 months.
•  < 1month of age — 1000 IU/d;
• 2-12 months of age — 1000-3000 IU/d;
• Children >1 year of age — 5000 IU/d;
• Adults — up to 7000 IU/d;
• Serum 25-OHD, alkaline phosphatase activity,
calcium, and calciuria should be assessed every
1–3 months.
A summary of current recommendations is summarized
in the algorithm.
Attention!
The Recommendation Committee underlines the lack
of substantive background to change vitamin D dos-
age, taking into account exclusively the crown of the
head, delayed dentition, delayed appearance of nucle-
uses of ossification in the head of the femur, craniota-
bes, and excessive sweating. Craniotabes in healthy in-
fants receiving recommended vitamin D dose does not
allow the diagnosis of rickets. Craniotabes could be sec-
ondary to excessive phosphate supply in the diet and
are also seen in completely healthy infants with high
body weight gains. If there is any doubt about vitamin
D status, assessment of calcium–phosphorus homeosta-
sis and 25-OHD levels should be assayed. If rickets is
suspected, radiogram of the wrist should be done addi-
tionally.
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